RENEW OR SUBSCRIBE TO PPM
Subscription is FREE for qualified healthcare professionals in the US.
RENEW | SUBSCRIBE
Home » Resources » News and Research
Subscribe or renew to PPM

All News and Research Articles

Two New Urine Drug Screens Get Approval for Quick In-Office Testing
Gaining clearance from the Food and Drug Administration (FDA), 2 new drug screening tests offer practitioner immediate, in-office results for the 5 most commonly abused opioid-derived drugs and for fentanyl.
New Opioid Program Raises Concerns for Chronic Pain Patients
Express Scripts launches an Advanced Opioid Management Program intended to limit new opioid prescriptions to no more than a week of short-acting formulations, which all but ignores pain specialists discretion and individual patient needs.
Polymyalgia Rheumatica and Steroid Side Effects: New Findings
Patients with polymyalgia rheumatica are not at greater risk of developing diabetes, osteoporosis, or fractures from long-term steroid therapy than patients without PMR, according to the results of a new study.
Bariatric Surgery for Obesity Improves Symptoms of Arthritis
Weight loss surgery may help overweight patients suffering from arthritis of the knee, new study finds.
Gabapentinoids for Chronic Low Back Pain? Not So Fast
Gabapentinoids are not a good substitute for opioids in the management of chronic low back pain that does not include neuropathic pain, study finds.
FDA Approves Syndros, First Liquid Form of Cannabinoid Dronabinol
New form of synthetic cannabinoid, Syndros, has received FDA approval for the treatment of cachexia and nausea and vomiting in AIDS and cancer patients.
New Indication for Movantik: Cancer Survivors With Chronic Pain
The FDA has expanded the indication for Movantik to include cancer survivors on opioid therapy for pain management who develop opioid-induced constipation.
Washington Declares War on Opioid Epidemic, Fraudulent Doctors
The government is declaring war on the opioid epidemic. Practical Pain Management takes a look at what that will mean for physicians and pain patients, and how to weather this storm.
Specific Brain Activity May Identify Patient Responsiveness to PTSD Treatment
Patients with post-traumatic stress disorder who improved following prolonged exposure therapy showed similar brain activity patterns following emotional tasks, indicating an ability to predict responsiveness.
New NDA for Non-Opioid Pain Medication
New Drug Application filed for IV meloxicam from Recro Pharma, Inc. Agent uses NanoCrystal platform to enhance bioavailability of the NSAID at lower doses.
Opioid Prescriptions Not Optimized for Post-Surgical Pain
While most patients received an opioid prescription to manage post-surgical pain, fewer than 10% of patients filled and used the full prescription.
Prevalence of Diabetic Peripheral Neuropathy in Youth Nears That of Adults
Youth with diabetes are developing diabetic peripheral neuropathy at rates similar to that of adults, necessitating more aggressive screening and earlier management.
Rexista, Generic Oxycodone, Fails Hurdle Toward Approval
FDA tables NDA for new oxycodone extended-release opioid Rexista (oxycodone), citing safety concerns.
FDA Approves First, Injectable Treatment for Lupus
GlaxoSmithKline received approval to market a once weekly, subcutaneous injectable version of belimumab for patients with SLE, which can be self-administered.
MultiGen 2 Radiofrequency Generator Gains FDA Clearance
A MultGen 2 Radiofrequency Generator gains FDA clearance to provide greater efficacy in ablation procedures to give patients greater pain relief for 1 year.
SHOW MAIN MENU
SHOW SUB MENU